<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00108524</url>
  </required_header>
  <id_info>
    <org_study_id>CLIN-005-03F</org_study_id>
    <nct_id>NCT00108524</nct_id>
  </id_info>
  <brief_title>A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss</brief_title>
  <official_title>A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares two types of diet interventions: a low carbohydrate ketogenic diet
      (Atkins) and a low-fat diet combined with a medication (Orlistat).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overweight and obesity are increasingly prevalent in the veteran population as well as the
      general public. For patients with obesity-associated illnesses, there are few effective
      treatment options available after failed attempts at diet and exercise, even though weight
      loss has been shown to alleviate these conditions. The purpose of this study is to compare
      the tolerability, safety, and efficacy of a low-carbohydrate ketogenic diet (Atkins) with a
      combination of a low-fat diet and Orlistat. The outcomes examined over a 48 week duration
      will include body weight, risk factors for heart disease (e.g., lipid profiles), and blood
      sugar. This is a randomized, parallel-intervention trial. Subjects (n=150) will be recruited
      from the Durham VAMC Ambulatory Care Clinics. All patients receive one of the two intensive
      weight loss interventions.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Body Weight at 48 Weeks</measure>
    <time_frame>baseline and 48 weeks</time_frame>
    <description>Body weight was measured using the same calibrated scale (Tanita Corp, Arlington Heights, Illinois) at each visit at the same time of day, with the participant wearing light clothing and no shoes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Risk Factors for Heart Disease (e.g., Lipid Profiles) at 48 Weeks</measure>
    <time_frame>baseline and 48 weeks</time_frame>
    <description>Measured change in low-density lipoprotein cholesterol, or LDL-C, from baseline to 48 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Blood Sugar at 48 Weeks</measure>
    <time_frame>Baseline and 48 weeks</time_frame>
    <description>Measured change in Fasting glucose, mg/dL, from baseline to 48 weeks.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">146</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Low Carbohydrate Ketogenic Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive dietary counseling over 48 weeks aimed at helping them to lower starch and sugar intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-Fat Diet plus Orlistat</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receive counseling on a low fat diet over 48 weeks aimed at reducing fat and calorie intake, and additionally receive Orlistat taken 3 times daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low carbohydrate ketogenic diet</intervention_name>
    <description>A low-carb diet limits carbohydrates - such as grains, starchy vegetables and fruit - and emphasizes dietary protein and fat.</description>
    <arm_group_label>Low Carbohydrate Ketogenic Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Orlistat</intervention_name>
    <description>In addition to the low fat diet, Orlistat is taken 3 times daily.</description>
    <arm_group_label>Low-Fat Diet plus Orlistat</arm_group_label>
    <other_name>Xenical</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low-fat diet</intervention_name>
    <description>Participants receive counseling on a low fat diet over 48 weeks aimed at reducing fat and calorie intake</description>
    <arm_group_label>Low-Fat Diet plus Orlistat</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants must have a VA medical center primary care provider;

          -  Failed first line diet and exercise recommendations;

          -  In stable health by screening physical and lab tests;

          -  Agrees to make regular visits per study protocol;

          -  Has access to telephone;

          -  Body mass index (BMI) &gt; or = 27 with obesity-related illness OR BMI &gt; or = 30 with no
             risk factors;

          -  No contraindications to Orlistat;

          -  Not pregnant or breast-feeding;

          -  No serious mental health illness such as dementia or schizophrenia;

          -  No use of a weight loss therapy in the month prior to screening.

        Exclusion Criteria:

          -  No VAMC primary care provider

          -  Unable to attend regular study visits

          -  No access to telephone

          -  BMI &lt; 27

          -  Contraindications to Orlistat

          -  Pregnancy, breast feeding or planning to become pregnant

          -  Unstable mental health illness

          -  Use of a weight loss therapy in the month prior to screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William S. Yancy, MD MHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Durham VA Medical Center HSR&amp;D COE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Durham VA Medical Center HSR&amp;D COE</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Mayer SB, Jeffreys AS, Olsen MK, McDuffie JR, Feinglos MN, Yancy WS Jr. Two diets with different haemoglobin A1c and antiglycaemic medication effects despite similar weight loss in type 2 diabetes. Diabetes Obes Metab. 2014 Jan;16(1):90-3. doi: 10.1111/dom.12191. Epub 2013 Aug 29.</citation>
    <PMID>23911112</PMID>
  </results_reference>
  <results_reference>
    <citation>Yancy WS Jr, Almirall D, Maciejewski ML, Kolotkin RL, McDuffie JR, Westman EC. Effects of two weight-loss diets on health-related quality of life. Qual Life Res. 2009 Apr;18(3):281-9. doi: 10.1007/s11136-009-9444-8. Epub 2009 Feb 11.</citation>
    <PMID>19212822</PMID>
  </results_reference>
  <results_reference>
    <citation>Yancy WS Jr, Westman EC, McDuffie JR, Grambow SC, Jeffreys AS, Bolton J, Chalecki A, Oddone EZ. A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss. Arch Intern Med. 2010 Jan 25;170(2):136-45. doi: 10.1001/archinternmed.2009.492. Erratum in: JAMA Intern Med. 2015 Mar;175(3):470.</citation>
    <PMID>20101008</PMID>
  </results_reference>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2005</study_first_submitted>
  <study_first_submitted_qc>April 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2005</study_first_posted>
  <results_first_submitted>September 26, 2013</results_first_submitted>
  <results_first_submitted_qc>September 26, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 12, 2013</results_first_posted>
  <last_update_submitted>March 26, 2014</last_update_submitted>
  <last_update_submitted_qc>March 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anti-obesity agents</keyword>
  <keyword>diet therapy</keyword>
  <keyword>diet, reducing</keyword>
  <keyword>obesity</keyword>
  <keyword>overweight</keyword>
  <keyword>risk factors</keyword>
  <keyword>weight loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Orlistat</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from outpatient clinics affiliated with the Department of Veterans Affairs Medical Center in Durham, North Carolina, between April 2005 and October 2006.</recruitment_details>
      <pre_assignment_details>18-70yo,BMI 27-30+obesity-related disease or BMI&gt;30 regardless of comorbidity. Excluded:weight loss in &lt;30 days;pregnant,breastfeeding,DM-1;unstable heart disease or psych illness,dementia,substance abuse;HTN &gt;160/100; creatinine&gt;1.5men,&gt;1.3women; HemA1c&gt;11%; triglyceride&gt;600; LDL-C&gt;190. Not considered enrolled if not told group assignment (n=14).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Low Carbohydrate Ketogenic Diet</title>
          <description>Participants receive dietary counseling over 48 weeks aimed at helping them to lower starch and sugar intake.
Low carbohydrate ketogenic diet: Participants were instructed to restrict carbohydrate intake initially to less than 20 g/d using pocket guides and handouts. Participants could eat unlimited meat and eggs, 112 g of hard cheese, 0.48 L of low-carbohydrate vegetables (eg, leafy greens), and 0.24 L of moderate-carbohydrate vegetables (eg, broccoli, asparagus) daily; calorie intake was not restricted. As participants approached their goal weight or if cravings threatened their adherence to the diet, they were advised to add approximately 5 g of carbohydrates to their daily intake each week until weight was maintained or cravings diminished.</description>
        </group>
        <group group_id="P2">
          <title>Low-Fat Diet Plus Orlistat</title>
          <description>Participants receive dietary counseling over 48 weeks aimed at reducing fat and calorie intake and additionally receive Orlistat taken 3 times daily.
Orlistat plus a low-fat diet: Participants were instructed to restrict intake of total fat (&lt;30% of daily energy), saturated fat (&lt;10% of daily energy), cholesterol (&lt;300 mg daily), and calories using pocket guides, handouts, and individualized goals. Recommended calorie intake was 500 to 1000 kcal below a participant's calculated weight maintenance intake. In addition, a 30-day supply of orlistat (120 mg before meals 3 times a day) was provided monthly.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="81"/>
                <participants group_id="P2" count="79"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>160 participants were randomized (81 allocated to LCKD, 79 to Orlistat plus LFD). 14 did not receive the intervention. 33 discontinued the intervention. Out of the 146 participants analyzed, 113 completed the intervention.</population>
      <group_list>
        <group group_id="B1">
          <title>Arm 1</title>
          <description>Participants receive dietary counseling over 48 weeks aimed at helping them to lower starch and sugar intake.
Low carbohydrate ketogenic diet: Participants were instructed to restrict carbohydrate intake initially to less than 20 g/d using pocket guides and handouts. Participants could eat unlimited meat and eggs, 112 g of hard cheese, 0.48 L of low-carbohydrate vegetables (eg, leafy greens), and 0.24 L of moderate-carbohydrate vegetables (eg, broccoli, asparagus) daily; calorie intake was not restricted. As participants approached their goal weight or if cravings threatened their adherence to the diet, they were advised to add approximately 5 g of carbohydrates to their daily intake each week until weight was maintained or cravings diminished.</description>
        </group>
        <group group_id="B2">
          <title>Arm 2</title>
          <description>Participants receive dietary counseling over 48 weeks aimed at reducing fat and calorie intake and additionally receive Orlistat taken 3 times daily.
Orlistat plus a low-fat diet: Participants were instructed to restrict intake of total fat (&lt;30% of daily energy), saturated fat (&lt;10% of daily energy), cholesterol (&lt;300 mg daily), and calories using pocket guides, handouts, and individualized goals. Recommended calorie intake was 500 to 1000 kcal below a participant's calculated weight maintenance intake. In addition, a 30-day supply of orlistat (120 mg before meals 3 times a day) was provided monthly.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="72"/>
            <count group_id="B2" value="74"/>
            <count group_id="B3" value="146"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.9" spread="10.2"/>
                    <measurement group_id="B2" value="52.0" spread="9.2"/>
                    <measurement group_id="B3" value="52" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Body Weight at 48 Weeks</title>
        <description>Body weight was measured using the same calibrated scale (Tanita Corp, Arlington Heights, Illinois) at each visit at the same time of day, with the participant wearing light clothing and no shoes.</description>
        <time_frame>baseline and 48 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Low carbohydrate ketogenic diet: Participants receive dietary counseling over 48 weeks aimed at helping them to lower starch and sugar intake.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>Orlistat plus a low-fat diet: Participants receive dietary counseling over 48 weeks aimed at reducing fat and calorie intake and additionally receive Orlistat taken 3 times daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Body Weight at 48 Weeks</title>
          <description>Body weight was measured using the same calibrated scale (Tanita Corp, Arlington Heights, Illinois) at each visit at the same time of day, with the participant wearing light clothing and no shoes.</description>
          <units>percentage of weight loss</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="72"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.5" lower_limit="-14.8" upper_limit="-7.9"/>
                    <measurement group_id="O2" value="-8.5" lower_limit="-11.0" upper_limit="-6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Risk Factors for Heart Disease (e.g., Lipid Profiles) at 48 Weeks</title>
        <description>Measured change in low-density lipoprotein cholesterol, or LDL-C, from baseline to 48 weeks.</description>
        <time_frame>baseline and 48 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Low carbohydrate ketogenic diet: Participants receive dietary counseling over 48 weeks aimed at helping them to lower starch and sugar intake.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>Orlistat plus a low-fat diet: Participants receive dietary counseling over 48 weeks aimed at reducing fat and calorie intake and additionally receive Orlistat taken 3 times daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Risk Factors for Heart Disease (e.g., Lipid Profiles) at 48 Weeks</title>
          <description>Measured change in low-density lipoprotein cholesterol, or LDL-C, from baseline to 48 weeks.</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="72"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.91" lower_limit="-8.14" upper_limit="4.33"/>
                    <measurement group_id="O2" value="-8.29" lower_limit="-14.06" upper_limit="-2.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Blood Sugar at 48 Weeks</title>
        <description>Measured change in Fasting glucose, mg/dL, from baseline to 48 weeks.</description>
        <time_frame>Baseline and 48 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Low carbohydrate ketogenic diet: Participants receive dietary counseling over 48 weeks aimed at helping them to lower starch and sugar intake.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>Orlistat plus a low-fat diet: Participants receive dietary counseling over 48 weeks aimed at reducing fat and calorie intake and additionally receive Orlistat taken 3 times daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Blood Sugar at 48 Weeks</title>
          <description>Measured change in Fasting glucose, mg/dL, from baseline to 48 weeks.</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="72"/>
                <count group_id="O2" value="74"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.74" lower_limit="-16.93" upper_limit="-2.55"/>
                    <measurement group_id="O2" value="-3.54" lower_limit="-10.05" upper_limit="-3.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>48 weeks</time_frame>
      <desc>The O + LFD participants reported gastrointestinal effects more frequently than the LCKD participants, occurring predominantly after dietary indiscretions. The LCKD had its own gastrointestinal adverse effect, constipation, in most cases resolving by increasing fluid and dietary fiber intake and/or adding a fiber supplement or stool softener.</desc>
      <group_list>
        <group group_id="E1">
          <title>Arm 1</title>
          <description>Low carbohydrate ketogenic diet: Participants receive dietary counseling over 48 weeks aimed at helping them to lower starch and sugar intake.</description>
        </group>
        <group group_id="E2">
          <title>Arm 2</title>
          <description>Orlistat plus a low-fat diet: Participants receive dietary counseling over 48 weeks aimed at reducing fat and calorie intake and additionally receive Orlistat taken 3 times daily.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>gastrointestinal symptoms</sub_title>
                <description>1 participant discontinued orlistat treatment due to intolerance of gastrointestinal symptoms.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="72"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>constipation</sub_title>
                <description>constipation</description>
                <counts group_id="E1" events="49" subjects_affected="49" subjects_at_risk="72"/>
                <counts group_id="E2" events="30" subjects_affected="30" subjects_at_risk="74"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>We provided orlistat at no cost. This could have increased dietary adherence, attendance, and/or retention compared with the LCKD and may lead to different results than what might be seen in patients who must pay for orlistat.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>William S Yancy, Jr. MD, MHSc</name_or_title>
      <organization>Durham VAMC</organization>
      <phone>919-286-0411 ext 7770</phone>
      <email>william.yancy2@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

